Cryptogenic Stroke and Significance of the Patent Foramen Ovale: A Case Series

被引：0

作者：

Pour-Ghaz, Issa ^{[1
]}

Krishnan, Rashi ^{[2
]}

Pierce, William F. ^{[1
]}

Jackson, Christopher D. ^{[1
]}

Bhole, Rohini ^{[3
]}

Seth, Ankur ^{[1
]}

机构：

[1] Univ Tennessee, Ctr Hlth Sci, Internal Med, Memphis, TN 38163 USA

[2] Univ Tennessee, Ctr Hlth Sci, Neurol, Memphis, TN 38163 USA

[3] Methodist Univ Hosp, Neurol, Memphis, TN USA

来源：

CUREUS | 2018年 / 10卷 / 10期

关键词：

patent foramen ovale; cryptogenic stroke; transient ischemic attack; pfo; pfo closure;

D O I：

10.7759/cureus.3525

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Stroke is the second leading cause of death globally and can lead to significant adverse outcomes in patients following the acute illness. Due to this high morbidity and mortality, adequate interventions can play a significant role in health outcomes. Patent foramen ovale is one of the major proposed causes of cryptogenic strokes and can be present in up to 25% of general population. In cryptogenic strokes, the relation of this structural heart defect is inversely proportional to age of patient. Here, we present three cases of cryptogenic strokes in patients with patent foramen ovale where it possibly plays a significant role. We demonstrate that in the younger age spectrum, patent foramen ovale plays a more significant role and treatment could prevent future stroke episodes.

引用

页数：9

共 20 条

[1] Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials [J].

Abo-salem, Elsayed ;

Chaitman, Bernard ;

Helmy, Tarek ;

Boakye, Eric Adjei ;

Alkhawam, Hassan ;

Lim, Michael .

JOURNAL OF NEUROLOGY, 2018, 265 (03) :578-585

[2] ATRIAL SEPTAL ANEURYSM AND PATENT FORAMEN OVALE AS RISK-FACTORS FOR CRYPTOGENIC STROKE IN PATIENTS LESS-THAN 55 YEARS OF AGE - A STUDY USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY [J].

CABANES, L ;

MAS, JL ;

COHEN, A ;

AMARENCO, P ;

CABANES, PA ;

OUBARY, P ;

CHEDRU, F ;

GUERIN, F ;

BOUSSER, MG ;

DERECONDO, J .

STROKE, 1993, 24 (12) :1865-1873

[3] Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke [J].

Carroll, John D. ;

Saver, Jeffrey L. ;

Thaler, David E. ;

Smalling, Richard W. ;

Berry, Scott ;

MacDonald, Lee A. ;

Marks, David S. ;

Tirschwell, David L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12) :1092-1100

[4] Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes? [J].

Dalen, James E. ;

Alpert, Joseph S. .

AMERICAN JOURNAL OF MEDICINE, 2018, 131 (03) :222-225

[5] Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale A Systematic Review and Meta-analysis [J].

De Rosa, Salvatore ;

Sievert, Horst ;

Sabatino, Jolanda ;

Polimeni, Alberto ;

Sorrentino, Sabato ;

Indolfi, Ciro .

ANNALS OF INTERNAL MEDICINE, 2018, 168 (05) :343-+

[6] Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale [J].

Furlan, Anthony J. ;

Reisman, Mark ;

Massaro, Joseph ;

Mauri, Laura ;

Adams, Harold ;

Albers, Gregory W. ;

Felberg, Robert ;

Herrmann, Howard ;

Kar, Saibal ;

Landzberg, Michael ;

Raizner, Albert ;

Wechsler, Lawrence .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) :991-999

[7] Stroke prevention [J].

Isabel, Clothilde ;

Calvet, David ;

Mas, Jean-Louis .

PRESSE MEDICALE, 2016, 45 (12) :E457-E471

[8] Patent foramen ovale closure to prevent secondary neurologic events [J].

Jasper, Rosie ;

Blankenship, James C. .

EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 44 :1-11

[9] Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an inter-atrial septal aneurysm or both [J].

Lim, Soon Tjin ;

Murphy, Stephen J. X. ;

Smith, Deirdre R. ;

Williams, Jennifer ;

Navarro, Silvia Gil ;

McCabe, John ;

Moore, David P. ;

McHugh, Johnny ;

McCabe, Dominick J. H. .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 :227-233

[10] Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke [J].

Mas, J. -L. ;

Derumeaux, G. ;

Guillon, B. ;

Massardier, E. ;

Hosseini, H. ;

Mechtouff, L. ;

Arquizan, C. ;

Bejot, Y. ;

Vuillier, F. ;

Detante, O. ;

Guidoux, C. ;

Canaple, S. ;

Vaduva, C. ;

Dequatre-Ponchelle, N. ;

Sibon, I. ;

Garnier, P. ;

Ferrier, A. ;

Timsit, S. ;

Robinet-Borgomano, E. ;

Sablot, D. ;

Lacour, J. -C. ;

Zuber, M. ;

Favrole, P. ;

Pinel, J. -F. ;

Apoil, M. ;

Reiner, P. ;

Lefebvre, C. ;

Guerin, P. ;

Piot, C. ;

Rossi, R. ;

Dubois-Rande, J. -L. ;

Eicher, J. -C. ;

Meneveau, N. ;

Lusson, J. -R. ;

Bertrand, B. ;

Schleich, J. -M. ;

Godart, F. ;

Thambo, J. -B. ;

Leborgne, L. ;

Michel, P. ;

Pierard, L. ;

Turc, G. ;

Barthelet, M. ;

Charles-Nelson, A. ;

Weimar, C. ;

Moulin, T. ;

Juliard, J. -M. ;

Chatellier, G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (11) :1011-1021

← 1 2 →